Viveque Egsgaard Nielsen

Author

Odense University Hospital ORCID

Also Known As

Viveque E Nielsen, Viveque E. Nielsen, Viveque Egsgaard Nielsen, Viveque Nielsen

Publications

873

Citations

H-Index

Concepts

All Affiliations

Odense University Hospital Aarhus University Hospital Aarhus University

About

Viveque Egsgaard Nielsen is an author at Odense University Hospital specializing in medicine, health sciences, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	96
2	Health Sciences	2	2	69
3	Pathology	2	2	46
4	Dosimetry	1	1	50
5	Head And Neck Cancer	1	1	27

Viveque Egsgaard Nielsen

Publications

713

Citations

H-Index

Page 1

	Year	Citations
Stimulation With 0.3-mg Recombinant Human Thyrotropin Prior to Iodine 131 Therapy to Improve the Size Reduction of Benign Nontoxic Nodular Goiter Viveque Egsgaard Nielsen, Steen Joop Bonnema, Henrik Boel-Jørgensen, Archives of Internal Medicine	2006	95
Improvement of Goiter Volume Reduction after 0.3 mg Recombinant Human Thyrotropin-Stimulated Radioiodine Therapy in Patients with a Very Large Goiter: A Double-Blinded, Randomized Trial Steen Joop Bonnema, Viveque Egsgaard Nielsen, Henrik Boel-Jørgensen, The Journal of Clinical Endocrinology & Metabolism	2007	89
Transient Goiter Enlargement after Administration of 0.3 mg of Recombinant Human Thyrotropin in Patients with Benign Nontoxic Nodular Goiter: A Randomized, Double-Blind, Crossover Trial Viveque Egsgaard Nielsen, Steen Joop Bonnema, László Hegedüs The Journal of Clinical Endocrinology & Metabolism	2006	61
Recombinant Human Thyrotropin-Stimulated Radioiodine Therapy of Large Nodular Goiters Facilitates Tracheal Decompression and Improves Inspiration Steen Joop Bonnema, Viveque Egsgaard Nielsen, Henrik Boel-Jørgensen, The Journal of Clinical Endocrinology & Metabolism	2008	53
Recombinant Human Thyrotropin Markedly Changes the<sup>131</sup>I Kinetics during<sup>131</sup>I Therapy of Patients with Nodular Goiter: An Evaluation by a Randomized Double-Blinded Trial Viveque Egsgaard Nielsen, Steen Joop Bonnema, Henrik Boel-Jørgensen, The Journal of Clinical Endocrinology & Metabolism Translational MedicineNuclear MedicineRandomized Double-blinded TrialHealth SciencesNodular Goiter	2005	50
Effects of 0.9 mg Recombinant Human Thyrotropin on Thyroid Size and Function in Normal Subjects: A Randomized, Double-Blind, Cross-Over Trial Viveque Egsgaard Nielsen, Steen Joop Bonnema, László Hegedüs The Journal of Clinical Endocrinology & Metabolism	2004	47
Recombinant Human Thyrotropin-Stimulated Radioiodine Therapy of Nodular Goiter Allows Major Reduction of the Radiation Burden with Retained Efficacy Søren Fast, Laszlo Hegedüs, Peter Grupe, The Journal of Clinical Endocrinology & Metabolism	2010	44
Optimizing <sup>131</sup>I Uptake After rhTSH Stimulation in Patients with Nontoxic Multinodular Goiter: Evidence from a Prospective, Randomized, Double-Blind Study Søren Fast, Viveque Egsgaard Nielsen, Peter Grupe, Journal of Nuclear Medicine	2009	42
Prestimulation with Recombinant Human Thyrotropin (rhTSH) Improves the Long-Term Outcome of Radioiodine Therapy for Multinodular Nontoxic Goiter Søren Fast, Viveque Egsgaard Nielsen, Peter Grupe, The Journal of Clinical Endocrinology & Metabolism	2012	41
Dose‐dependent acute effects of recombinant human TSH (rhTSH) on thyroid size and function: comparison of 0·1, 0·3 and 0·9 mg of rhTSH Søren Fast, Viveque Egsgaard Nielsen, Steen Joop Bonnema, Clinical Endocrinology	2009	35

Page 1